Alkyl-substituted alpha-carboline analogue or pharmaceutical salt thereof, pharmaceutical composition thereof, and preparation method and application of alkyl-substituted alpha-carboline analogue or pharmaceutical salt thereof

The invention discloses a hydrocarbyl-substituted alpha-carboline analogue or a pharmaceutical salt thereof and a pharmaceutical composition thereof, which not only have anti-neuritis activity, but also can effectively protect nerve cells from being influenced by oxidative stress, can be used for preventing and/or treating diseases, and can be used for preventing and/or treating diseases. The diseases comprise neurodegenerative diseases (such as Alzheimer's disease), neuritis diseases (such as cranial neuritis) and the like, and the defect that current cholinergic drugs can only relieve symptoms of the neurodegenerative diseases (such as Alzheimer's disease) can be overcome..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 06. Juni Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

DAN WENJIA [VerfasserIn]
SUN YIFAN [VerfasserIn]
LIU JINYI [VerfasserIn]
GAO JIXIANG [VerfasserIn]
DAI JIANGKUN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-06-06, Last update posted on www.tib.eu: 2023-09-26, Last updated: 2023-09-29

Patentnummer:

CN116217567

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA002420074